We are live on
!
Find out more
TI
Trexquant Investment Portfolio holdings
AUM
$13.9B
1-Year Est. Return
31.98%
This Fund
S&P 500
This Quarter
Est. Return
-17.36%
1 Year Est. Return
+31.98%
3 Year Est. Return
+90.18%
5 Year Est. Return
+73.02%
10 Year Est. Return
+326.84%
AUM
$2.23B
AUM Growth
+$103M
(+4.8%)
Cap. Flow
+$535M
Cap. Flow
% of AUM
23.99%
Top 10 Holdings %
Top 10 Hldgs %
8.4%
Holding
2,002
New
707
Increased
438
Reduced
325
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$23.7M |
| 2 |
American Express
AXP
|
+$22.5M |
| 3 |
Accenture
ACN
|
+$22.4M |
| 4 |
PayPal
PYPL
|
+$22.3M |
| 5 |
Marathon Petroleum
MPC
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$20.5M |
| 2 |
Micron Technology
MU
|
+$19.9M |
| 3 |
Verizon
VZ
|
+$15.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$14M |
| 5 |
General Motors
GM
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.6% |
| 2 | Consumer Discretionary | 14.41% |
| 3 | Healthcare | 13.79% |
| 4 | Financials | 12.31% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Enanta Pharmaceuticals
ENTA
$367M
| $296K | 0.01% |
+6,252
| New | +$339K |
|
1127
Toronto Dominion Bank
TD
$199B
| $296K | 0.01% |
+4,511
| New | +$328K |
|
1128
BioMarin Pharmaceuticals
BMRN
$12B
| $295K | 0.01% |
3,555
-36,379
| -91% | -$2.9M |
|
|
DRD
1129
DRDGold
DRD
$1.79B
| $295K | 0.01% |
50,314
+22,441
| +81% | +$166K |
|
|
PLYA
1130
DELISTED
Playa Hotels & Resorts
PLYA
| $295K | 0.01% |
42,899
-21,104
| -33% | -$175K |
|
1131
Pentair
PNR
$10.8B
| $295K | 0.01% |
+6,451
| New | +$323K |
|
1132
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $295K | 0.01% |
+4,313
| New | +$321K |
|
1133
iShares US Telecommunications ETF
IYZ
$1.19B
| $294K | 0.01% |
11,682
+725
| +7% | +$19.6K |
|
1134
Commercial Metals
CMC
$7.8B
| $293K | 0.01% |
+8,847
| New | +$348K |
|
1135
Endava
DAVA
$153M
| $293K | 0.01% |
+3,319
| New | +$347K |
|
1136
Pacific Biosciences
PACB
$432M
| $293K | 0.01% |
+66,360
| New | +$403K |
|
1137
Zymeworks
ZYME
$1.66B
| $292K | 0.01% |
+55,110
| New | +$333K |
|
|
AMED
1138
DELISTED
Amedisys
AMED
| $291K | 0.01% |
+2,769
| New | +$354K |
|
|
FOLD
1139
DELISTED
Amicus Therapeutics
FOLD
| $291K | 0.01% |
+27,077
| New | +$223K |
|
|
MRUS
1140
DELISTED
Merus
MRUS
| $291K | 0.01% |
+12,852
| New | +$268K |
|
1141
JPMorgan BetaBuilders Europe ETF
BBEU
$9.22B
| $290K | 0.01% |
+6,288
| New | +$320K |
|
1142
Celanese
CE
$4.77B
| $290K | 0.01% |
+2,463
| New | +$353K |
|
1143
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
| $290K | 0.01% |
+3,194
| New | +$308K |
|
1144
Perdoceo Education
PRDO
$2.06B
| $290K | 0.01% |
+24,654
| New | +$270K |
|
1145
iShares MSCI USA Value Factor ETF
VLUE
$9.29B
| $290K | 0.01% |
+3,206
| New | +$317K |
|
1146
Consolidated Water Co
CWCO
$484M
| $289K | 0.01% |
19,965
-13,374
| -40% | -$166K |
|
|
PRFT
1147
DELISTED
Perficient Inc
PRFT
| $289K | 0.01% |
+3,153
| New | +$314K |
|
1148
Yeti Holdings
YETI
$3.93B
| $288K | 0.01% |
6,659
-5,948
| -47% | -$289K |
|
1149
The Ensign Group
ENSG
$10.7B
| $287K | 0.01% |
+3,908
| New | +$312K |
|
1150
MarineMax
HZO
$782M
| $286K | 0.01% |
7,910
-12,829
| -62% | -$515K |
|
Similar funds
SAM
CM
X
WHG
PSCM
BIP
SA
FGP
Trexquant Investment's Q2 2022 Portfolio in Review
As of Q2 2022, Trexquant Investment held 2,002 positions worth $2.23B, up 4.8% from $2.13B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Trexquant Investment deployed $535M of net new capital in Q2 2022, opening 707 new positions and adding to 438 existing holdings. Its largest new stake was Idexx Laboratories: 58,009 shares worth $20.3M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $19.9M trimmed.
- Trexquant Investment's largest Q2 2022 buy was Idexx Laboratories: 58,009 shares worth $20.3M.
- Trexquant Investment added most to American Express in Q2 2022, an estimated $22.5M increase.
- Trexquant Investment's biggest Q2 2022 reduction was Micron Technology, cutting an estimated $19.9M.
- Trexquant Investment fully exited Analog Devices in Q2 2022, selling an estimated $20.5M.
- Trexquant Investment's ten largest holdings make up 8.4% of its $2.23B portfolio in Q2 2022.
- Trexquant Investment opened 707 new positions and closed 532 in Q2 2022.
- Trexquant Investment's portfolio value rose 4.8% quarter-over-quarter to $2.23B.
Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.